Lv3
260 积分 2023-03-12 加入
Long Term HBsAg Responses to Peg-Interferon Alpha-2b in HBeAg Negative Chronic Hepatitis B Patients Developing Clinical Relapse after Stopping Long-Term Nucleos(t)ide Analogue Therapy
3天前
已完结
Mechanism of interferon alpha therapy for chronic hepatitis B and potential approaches to improve its therapeutic efficacy
3天前
已完结
非活动性HBsAg携带状态抗病毒治疗的利与弊
1个月前
已关闭
[Is it appropriate for the "Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)" to require HBeAg-negative chronic HBV-infected patients to be HBV DNA-negative?]
1个月前
已完结
Single-cell RNA sequencing reveals the immunoregulatory roles of PegIFN-α in patients with chronic hepatitis B
1个月前
已完结
Prevalence of Non-Alcoholic Fatty Liver Disease and Its Impact on Fibrosis Risk in Inactive Chronic Hepatitis B Patients: Insights from a Cross-Sectional Study
1个月前
已完结
FRI-396 Risk of hepatocellular carcinoma decreases after antiviral therapy-induced HBsAg seroclearance
1个月前
已关闭
The performance of hepatitis B surface antigen quantification as a noninvasive biomarker predicting liver injury and serum hepatitis B virus DNA level
2个月前
已完结
Countdown on hepatitis B elimination by 2030: the global burden of liver disease related to hepatitis B and association with socioeconomic status
2个月前
已完结
Relationship between serum HBV DNA level and liver histology in HBV carriers with normal ALT in Guilan province, Iran
3个月前
已关闭
皖公网安备34019202002308
